LGR5 and acute myeloid leukemia: Similarly, the chemotherapeutic drug Adriamycin (doxorubicin hydrochloride), commonly used to treat AML, also induces intestinal damage, although in this case Lgr5+ stem cells are thought to play a less critical role in recovery (Dekaney et al., 2009).